(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 1118.39 | 1190.19 | -6.03 | 1118.39 | 1190.19 | -6.03 | 4502.53 | 4305.32 | 4.58 |
| Other Income | 48.97 | 88.41 | -44.61 | 48.97 | 88.41 | -44.61 | 238.99 | 116.78 | 104.65 |
| PBIDT | 278.70 | 313.72 | -11.16 | 278.70 | 313.72 | -11.16 | 1146.96 | 1117.93 | 2.60 |
| Interest | 25.39 | 31.05 | -18.23 | 25.39 | 31.05 | -18.23 | 114.84 | 141.99 | -19.12 |
| PBDT | 253.31 | 282.67 | -10.39 | 253.31 | 282.67 | -10.39 | 1101.78 | 975.94 | 12.89 |
| Depreciation | 51.86 | 55.47 | -6.51 | 51.86 | 55.47 | -6.51 | 209.36 | 231.73 | -9.65 |
| PBT | 201.45 | 227.20 | -11.33 | 201.45 | 227.20 | -11.33 | 892.42 | 744.21 | 19.92 |
| TAX | 51.60 | 64.85 | -20.43 | 51.60 | 64.85 | -20.43 | 249.58 | 68.05 | 266.76 |
| Deferred Tax | 7.99 | 24.82 | -67.81 | 7.99 | 24.82 | -67.81 | 103.50 | -63.17 | -263.84 |
| PAT | 149.85 | 162.35 | -7.70 | 149.85 | 162.35 | -7.70 | 642.84 | 676.16 | -4.93 |
| Equity | 143.40 | 145.84 | -1.67 | 143.40 | 145.84 | -1.67 | 143.35 | 145.84 | -1.71 |
| PBIDTM(%) | 24.92 | 26.36 | -5.46 | 24.92 | 26.36 | -5.46 | 25.47 | 25.97 | -1.90 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1900.90 |
| Dr. Reddys Labs. | 1175.00 |
| Cipla | 1426.20 |
| Lupin | 2193.00 |
| Zydus Lifesciences | 1120.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: